Chimeric receptor, Cytotoxic T lympocyte, Fab, MHC, T cellreceptor, Tumor rejection antigen,
Gene Therapy
Department of Medical Oncology

Willemsen, R.A, Debets, J.E.M.A, Hart, E, Hoogenboom, L.C.A, Bolhuis, R.L.H, & Chames, P. (2001). A phage display selected Fab fragment with MHC class i-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes. Gene Therapy, 8(21), 1601–1608. doi:10.1038/